Compare CLDX & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | NTB |
|---|---|---|
| Founded | N/A | 1858 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1995 | 2016 |
| Metric | CLDX | NTB |
|---|---|---|
| Price | $29.00 | $50.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $44.50 | ★ $53.75 |
| AVG Volume (30 Days) | ★ 813.3K | 135.7K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $97.61 | $0.88 |
| Revenue Next Year | $252.01 | $4.21 |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $14.40 | $34.86 |
| 52 Week High | $31.31 | $55.84 |
| Indicator | CLDX | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 44.50 |
| Support Level | $24.70 | $43.75 |
| Resistance Level | $30.50 | $51.72 |
| Average True Range (ATR) | 1.52 | 1.52 |
| MACD | 0.78 | -0.29 |
| Stochastic Oscillator | 77.87 | 21.55 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.